These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
ý
|
Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
|
||
|
For the quarterly period ended September 30, 2015
|
||
¨
|
Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
|
||
|
For the transition period from to
|
|
|
|
|
|
|
Delaware
|
|
13-3728359
|
(State or Other Jurisdiction of
Incorporation or Organization)
|
|
(I.R.S. Employer
Identification No.)
|
|
|
|
Glenpointe Centre West
500 Frank W. Burr Blvd.
Teaneck, New Jersey
|
|
07666
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
|
|
|
Large accelerated filer
|
ý
|
Accelerated filer
|
¨
|
|
|
|
|
Non-accelerated filer
|
¨
(Do not check if a smaller reporting company)
|
Smaller reporting company
|
¨
|
Class
|
|
Number of Shares
|
Class A Common Stock, par value $.01 per share
|
|
608,068,826
|
|
|
|
|
|
Page
|
PART I.
|
||
|
|
|
Item 1.
|
||
|
|
|
|
||
|
|
|
|
Condensed Consolidated Statements of Operations (Unaudited) for the Three Months Ended
September 30, 2015 and 2014 and for the Nine Months Ended September 30, 2015 and 2014
|
|
|
|
|
|
Condensed Consolidated Statements of Comprehensive Income (Unaudited) for the Three Months Ended
September 30, 2015 and 2014 and for the Nine Months Ended September 30, 2015 and 2014
|
|
|
|
|
|
Condensed Consolidated Statements of Cash Flows (Unaudited) for the
Nine Months Ended September 30, 2015 and 2014
|
|
|
|
|
|
||
|
|
|
Item 2.
|
||
|
|
|
Item 3.
|
||
|
|
|
Item 4.
|
||
|
|
|
PART II.
|
||
|
|
|
Item 1A.
|
||
|
|
|
Item 2.
|
||
|
|
|
Item 6.
|
||
|
|
|
|
September 30,
2015 |
|
December 31,
2014 |
||||
Assets
|
|
|
|
||||
Current assets:
|
|
|
|
||||
Cash and cash equivalents
|
$
|
1,476.7
|
|
|
$
|
2,010.1
|
|
Short-term investments
|
2,574.0
|
|
|
1,764.6
|
|
||
Trade accounts receivable, net of allowances of $39.5 and $36.9, respectively
|
2,135.7
|
|
|
1,968.7
|
|
||
Unbilled accounts receivable
|
420.9
|
|
|
324.6
|
|
||
Deferred income tax assets, net
|
365.9
|
|
|
329.7
|
|
||
Other current assets
|
264.7
|
|
|
352.6
|
|
||
Total current assets
|
7,237.9
|
|
|
6,750.3
|
|
||
Property and equipment, net of accumulated depreciation of $1,013.4 and $852.1, respectively
|
1,278.9
|
|
|
1,247.2
|
|
||
Goodwill
|
2,403.6
|
|
|
2,413.6
|
|
||
Intangible assets, net
|
881.4
|
|
|
953.7
|
|
||
Deferred income tax assets, net
|
203.7
|
|
|
144.4
|
|
||
Other noncurrent assets
|
262.1
|
|
|
209.7
|
|
||
Total assets
|
$
|
12,267.6
|
|
|
$
|
11,718.9
|
|
Liabilities and Stockholders’ Equity
|
|
|
|
||||
Current liabilities:
|
|
|
|
||||
Accounts payable
|
$
|
160.1
|
|
|
$
|
145.7
|
|
Deferred revenue
|
262.7
|
|
|
224.1
|
|
||
Short-term debt
|
50.0
|
|
|
700.0
|
|
||
Accrued expenses and other current liabilities
|
1,655.6
|
|
|
1,522.3
|
|
||
Total current liabilities
|
2,128.4
|
|
|
2,592.1
|
|
||
Deferred revenue, noncurrent
|
53.0
|
|
|
81.0
|
|
||
Deferred income tax liabilities, net
|
230.0
|
|
|
251.7
|
|
||
Long-term debt
|
900.0
|
|
|
937.5
|
|
||
Other noncurrent liabilities
|
129.2
|
|
|
116.4
|
|
||
Total liabilities
|
3,440.6
|
|
|
3,978.7
|
|
||
Commitments and contingencies (See Note 8)
|
|
|
|
||||
Stockholders’ Equity:
|
|
|
|
||||
Preferred stock, $0.10 par value, 15.0 shares authorized, none issued
|
—
|
|
|
—
|
|
||
Class A common stock, $0.01 par value, 1,000.0 shares authorized, 608.0 and 609.4 shares issued and outstanding at September 30, 2015 and December 31, 2014, respectively
|
6.1
|
|
|
6.1
|
|
||
Additional paid-in capital
|
432.4
|
|
|
555.6
|
|
||
Retained earnings
|
8,501.8
|
|
|
7,301.6
|
|
||
Accumulated other comprehensive income (loss)
|
(113.3
|
)
|
|
(123.1
|
)
|
||
Total stockholders’ equity
|
8,827.0
|
|
|
7,740.2
|
|
||
Total liabilities and stockholders’ equity
|
$
|
12,267.6
|
|
|
$
|
11,718.9
|
|
|
Three Months Ended
September 30, |
|
Nine Months Ended
September 30, |
||||||||||||
|
2015
|
|
2014
|
|
2015
|
|
2014
|
||||||||
Revenues
|
$
|
3,187.0
|
|
|
$
|
2,581.0
|
|
|
$
|
9,183.5
|
|
|
$
|
7,520.5
|
|
Operating expenses:
|
|
|
|
|
|
|
|
||||||||
Cost of revenues (exclusive of depreciation and amortization expense shown separately below)
|
1,934.6
|
|
|
1,569.8
|
|
|
5,506.6
|
|
|
4,501.7
|
|
||||
Selling, general and administrative expenses
|
627.1
|
|
|
506.0
|
|
|
1,849.9
|
|
|
1,474.4
|
|
||||
Depreciation and amortization expense
|
82.5
|
|
|
47.7
|
|
|
238.4
|
|
|
138.9
|
|
||||
Income from operations
|
542.8
|
|
|
457.5
|
|
|
1,588.6
|
|
|
1,405.5
|
|
||||
Other income (expense), net:
|
|
|
|
|
|
|
|
||||||||
Interest income
|
20.7
|
|
|
17.2
|
|
|
56.3
|
|
|
44.8
|
|
||||
Interest expense
|
(4.3
|
)
|
|
(0.3
|
)
|
|
(13.4
|
)
|
|
(0.3
|
)
|
||||
Foreign currency exchange gains (losses), net
|
(15.8
|
)
|
|
(11.2
|
)
|
|
(28.4
|
)
|
|
(13.2
|
)
|
||||
Other, net
|
(0.4
|
)
|
|
0.5
|
|
|
(0.7
|
)
|
|
2.0
|
|
||||
Total other income (expense), net
|
0.2
|
|
|
6.2
|
|
|
13.8
|
|
|
33.3
|
|
||||
Income before provision for income taxes
|
543.0
|
|
|
463.7
|
|
|
1,602.4
|
|
|
1,438.8
|
|
||||
Provision for income taxes
|
145.8
|
|
|
108.1
|
|
|
402.2
|
|
|
362.4
|
|
||||
Net income
|
$
|
397.2
|
|
|
$
|
355.6
|
|
|
$
|
1,200.2
|
|
|
$
|
1,076.4
|
|
Basic earnings per share
|
$
|
0.65
|
|
|
$
|
0.58
|
|
|
$
|
1.97
|
|
|
$
|
1.77
|
|
Diluted earnings per share
|
$
|
0.65
|
|
|
$
|
0.58
|
|
|
$
|
1.96
|
|
|
$
|
1.76
|
|
Weighted average number of common shares outstanding - Basic
|
608.8
|
|
|
608.1
|
|
|
609.4
|
|
|
607.9
|
|
||||
Dilutive effect of shares issuable under stock-based compensation plans
|
3.9
|
|
|
4.0
|
|
|
4.1
|
|
|
4.5
|
|
||||
Weighted average number of common shares outstanding - Diluted
|
612.7
|
|
|
612.1
|
|
|
613.5
|
|
|
612.4
|
|
|
Three Months Ended
September 30, |
|
Nine Months Ended
September 30, |
||||||||||||
|
2015
|
|
2014
|
|
2015
|
|
2014
|
||||||||
Net income
|
$
|
397.2
|
|
|
$
|
355.6
|
|
|
$
|
1,200.2
|
|
|
$
|
1,076.4
|
|
Other comprehensive income (loss), net of tax:
|
|
|
|
|
|
|
|
||||||||
Foreign currency translation adjustments
|
(16.8
|
)
|
|
(32.0
|
)
|
|
(34.4
|
)
|
|
(30.8
|
)
|
||||
Change in unrealized losses on cash flow hedges, net of taxes
|
(6.8
|
)
|
|
21.6
|
|
|
42.3
|
|
|
184.1
|
|
||||
Change in unrealized gains and losses on available-for-sale securities, net of taxes
|
0.8
|
|
|
(1.8
|
)
|
|
1.9
|
|
|
(0.7
|
)
|
||||
Other comprehensive income (loss)
|
(22.8
|
)
|
|
(12.2
|
)
|
|
9.8
|
|
|
152.6
|
|
||||
Comprehensive income
|
$
|
374.4
|
|
|
$
|
343.4
|
|
|
$
|
1,210.0
|
|
|
$
|
1,229.0
|
|
|
For the Nine Months Ended
September 30, |
||||||
|
2015
|
|
2014
|
||||
Cash flows from operating activities:
|
|
|
|
||||
Net income
|
$
|
1,200.2
|
|
|
$
|
1,076.4
|
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
|
|
|
||||
Depreciation and amortization
|
242.0
|
|
|
145.2
|
|
||
Provision for doubtful accounts
|
8.4
|
|
|
2.9
|
|
||
Deferred income taxes
|
(107.3
|
)
|
|
(43.4
|
)
|
||
Stock-based compensation expense
|
141.6
|
|
|
100.6
|
|
||
Excess tax benefits on stock-based compensation plans
|
(19.0
|
)
|
|
(14.5
|
)
|
||
Other
|
27.9
|
|
|
12.8
|
|
||
Changes in assets and liabilities:
|
|
|
|
||||
Trade accounts receivable
|
(190.6
|
)
|
|
(167.7
|
)
|
||
Other current assets
|
(7.6
|
)
|
|
(75.8
|
)
|
||
Other noncurrent assets
|
(40.1
|
)
|
|
22.9
|
|
||
Accounts payable
|
16.8
|
|
|
44.6
|
|
||
Other current and noncurrent liabilities
|
191.0
|
|
|
44.8
|
|
||
Net cash provided by operating activities
|
1,463.3
|
|
|
1,148.8
|
|
||
Cash flows from investing activities:
|
|
|
|
||||
Purchases of property and equipment
|
(198.7
|
)
|
|
(137.5
|
)
|
||
Purchases of investments
|
(2,093.9
|
)
|
|
(2,180.3
|
)
|
||
Proceeds from maturity or sale of investments
|
1,262.2
|
|
|
1,702.7
|
|
||
Business combinations, net of cash acquired
|
—
|
|
|
(11.5
|
)
|
||
Net cash (used in) investing activities
|
(1,030.4
|
)
|
|
(626.6
|
)
|
||
Cash flows from financing activities:
|
|
|
|
||||
Issuance of common stock under stock-based compensation plans
|
98.9
|
|
|
49.9
|
|
||
Excess tax benefits on stock-based compensation plans
|
19.0
|
|
|
14.5
|
|
||
Repurchases of common stock
|
(383.2
|
)
|
|
(171.3
|
)
|
||
Debt issuance costs
|
—
|
|
|
(1.5
|
)
|
||
Repayment of term loan borrowings and capital lease obligations
|
(39.6
|
)
|
|
—
|
|
||
Net change in notes outstanding under the revolving credit facility
|
(650.0
|
)
|
|
—
|
|
||
Net cash (used in) financing activities
|
(954.9
|
)
|
|
(108.4
|
)
|
||
Effect of exchange rate changes on cash and cash equivalents
|
(11.4
|
)
|
|
(9.2
|
)
|
||
(Decrease) increase in cash and cash equivalents
|
(533.4
|
)
|
|
404.6
|
|
||
Cash and cash equivalents, beginning of year
|
2,010.1
|
|
|
2,213.0
|
|
||
Cash and cash equivalents, end of period
|
$
|
1,476.7
|
|
|
$
|
2,617.6
|
|
|
September 30, 2015
|
|
December 31, 2014
|
||||
|
(in millions)
|
||||||
Available-for-sale investment securities:
|
|
|
|
||||
U.S. Treasury and agency debt securities
|
$
|
549.9
|
|
|
$
|
544.7
|
|
Corporate and other debt securities
|
354.5
|
|
|
358.6
|
|
||
Certificates of deposit and commercial paper
|
553.8
|
|
|
4.6
|
|
||
Asset-backed securities
|
231.3
|
|
|
220.1
|
|
||
Municipal debt securities
|
121.9
|
|
|
112.8
|
|
||
Mutual funds
|
22.4
|
|
|
21.9
|
|
||
Total available-for-sale investment securities
|
1,833.8
|
|
|
1,262.7
|
|
||
Time deposits
|
740.2
|
|
|
501.9
|
|
||
Total short-term investments
|
$
|
2,574.0
|
|
|
$
|
1,764.6
|
|
|
Amortized
Cost
|
|
Unrealized
Gains
|
|
Unrealized
Losses
|
|
Fair
Value
|
||||||||
|
(in millions)
|
||||||||||||||
U.S. Treasury and agency debt securities
|
$
|
548.0
|
|
|
$
|
1.9
|
|
|
$
|
—
|
|
|
$
|
549.9
|
|
Corporate and other debt securities
|
354.4
|
|
|
0.5
|
|
|
(0.4
|
)
|
|
354.5
|
|
||||
Certificates of deposit and commercial paper
|
553.5
|
|
|
0.3
|
|
|
—
|
|
|
553.8
|
|
||||
Asset-backed securities
|
230.9
|
|
|
0.5
|
|
|
(0.1
|
)
|
|
231.3
|
|
||||
Municipal debt securities
|
121.4
|
|
|
0.5
|
|
|
—
|
|
|
121.9
|
|
||||
Mutual funds
|
24.9
|
|
|
0.1
|
|
|
(2.6
|
)
|
|
22.4
|
|
||||
Total available-for-sale investment securities
|
$
|
1,833.1
|
|
|
$
|
3.8
|
|
|
$
|
(3.1
|
)
|
|
$
|
1,833.8
|
|
|
Amortized
Cost
|
|
Unrealized
Gains
|
|
Unrealized
Losses
|
|
Fair
Value
|
||||||||
|
(in millions)
|
||||||||||||||
U.S. Treasury and agency debt securities
|
$
|
544.7
|
|
|
$
|
0.4
|
|
|
$
|
(0.4
|
)
|
|
$
|
544.7
|
|
Corporate and other debt securities
|
359.0
|
|
|
0.3
|
|
|
(0.7
|
)
|
|
358.6
|
|
||||
Certificates of deposit and commercial paper
|
4.6
|
|
|
—
|
|
|
—
|
|
|
4.6
|
|
||||
Asset-backed securities
|
220.4
|
|
|
0.1
|
|
|
(0.4
|
)
|
|
220.1
|
|
||||
Municipal debt securities
|
112.5
|
|
|
0.4
|
|
|
(0.1
|
)
|
|
112.8
|
|
||||
Mutual funds
|
23.9
|
|
|
0.3
|
|
|
(2.3
|
)
|
|
21.9
|
|
||||
Total available-for-sale investment securities
|
$
|
1,265.1
|
|
|
$
|
1.5
|
|
|
$
|
(3.9
|
)
|
|
$
|
1,262.7
|
|
|
Less than 12 Months
|
|
12 Months or More
|
|
Total
|
||||||||||||||||||
|
Fair
Value
|
|
Unrealized
Losses
|
|
Fair
Value
|
|
Unrealized
Losses
|
|
Fair
Value
|
|
Unrealized
Losses
|
||||||||||||
|
(in millions)
|
||||||||||||||||||||||
U.S. Treasury and agency debt securities
|
$
|
25.7
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
25.7
|
|
|
$
|
—
|
|
Corporate and other debt securities
|
138.3
|
|
|
(0.4
|
)
|
|
1.0
|
|
|
—
|
|
|
139.3
|
|
|
(0.4
|
)
|
||||||
Asset-backed securities
|
54.1
|
|
|
(0.1
|
)
|
|
7.5
|
|
|
—
|
|
|
61.6
|
|
|
(0.1
|
)
|
||||||
Municipal debt securities
|
15.7
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
15.7
|
|
|
—
|
|
||||||
Mutual funds
|
—
|
|
|
—
|
|
|
21.3
|
|
|
(2.6
|
)
|
|
21.3
|
|
|
(2.6
|
)
|
||||||
Total
|
$
|
233.8
|
|
|
$
|
(0.5
|
)
|
|
$
|
29.8
|
|
|
$
|
(2.6
|
)
|
|
$
|
263.6
|
|
|
$
|
(3.1
|
)
|
|
Less than 12 Months
|
|
12 Months or More
|
|
Total
|
||||||||||||||||||
|
Fair
Value
|
|
Unrealized
Losses
|
|
Fair
Value
|
|
Unrealized
Losses
|
|
Fair
Value
|
|
Unrealized
Losses
|
||||||||||||
|
(in millions)
|
||||||||||||||||||||||
U.S. Treasury and agency debt securities
|
$
|
256.9
|
|
|
$
|
(0.4
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
256.9
|
|
|
$
|
(0.4
|
)
|
Corporate and other debt securities
|
229.7
|
|
|
(0.7
|
)
|
|
—
|
|
|
—
|
|
|
229.7
|
|
|
(0.7
|
)
|
||||||
Certificates of deposit and commercial paper
|
3.7
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
3.7
|
|
|
—
|
|
||||||
Asset-backed securities
|
151.9
|
|
|
(0.3
|
)
|
|
2.8
|
|
|
(0.1
|
)
|
|
154.7
|
|
|
(0.4
|
)
|
||||||
Municipal debt securities
|
28.0
|
|
|
(0.1
|
)
|
|
—
|
|
|
—
|
|
|
28.0
|
|
|
(0.1
|
)
|
||||||
Mutual funds
|
—
|
|
|
—
|
|
|
20.7
|
|
|
(2.3
|
)
|
|
20.7
|
|
|
(2.3
|
)
|
||||||
Total
|
$
|
670.2
|
|
|
$
|
(1.5
|
)
|
|
$
|
23.5
|
|
|
$
|
(2.4
|
)
|
|
$
|
693.7
|
|
|
$
|
(3.9
|
)
|
|
Amortized
Cost
|
|
Fair
Value
|
||||
|
(in millions)
|
||||||
Due within one year
|
$
|
624.3
|
|
|
$
|
624.7
|
|
Due after one year up to two years
|
501.2
|
|
|
502.3
|
|
||
Due after two years up to three years
|
437.1
|
|
|
438.3
|
|
||
Due after three years up to four years
|
14.7
|
|
|
14.8
|
|
||
Asset-backed securities
|
230.9
|
|
|
231.3
|
|
||
Fixed income available-for-sale investment securities
|
$
|
1,808.2
|
|
|
$
|
1,811.4
|
|
|
Three Months Ended
September 30, |
|
Nine Months Ended
September 30, |
||||||||||||
|
2015
|
|
2014
|
|
2015
|
|
2014
|
||||||||
|
(in millions)
|
||||||||||||||
Proceeds from sales of available-for-sale investment securities
|
$
|
168.3
|
|
|
$
|
670.5
|
|
|
$
|
596.4
|
|
|
$
|
1,028.3
|
|
|
|
|
|
|
|
|
|
||||||||
Gross gains
|
$
|
0.2
|
|
|
$
|
0.6
|
|
|
$
|
1.1
|
|
|
$
|
1.4
|
|
Gross losses
|
(0.1
|
)
|
|
(0.1
|
)
|
|
(0.2
|
)
|
|
(0.2
|
)
|
||||
Net realized gains on sales of available-for-sale investment securities
|
$
|
0.1
|
|
|
$
|
0.5
|
|
|
$
|
0.9
|
|
|
$
|
1.2
|
|
|
September 30, 2015
|
|
December 31, 2014
|
||||
|
(in millions)
|
||||||
Compensation and benefits
|
$
|
1,053.4
|
|
|
$
|
906.8
|
|
Income taxes
|
63.4
|
|
|
23.8
|
|
||
Professional fees
|
67.5
|
|
|
82.7
|
|
||
Travel and entertainment
|
37.7
|
|
|
35.0
|
|
||
Customer volume incentives
|
228.9
|
|
|
192.1
|
|
||
Derivative financial instruments
|
30.7
|
|
|
97.3
|
|
||
Other
|
174.0
|
|
|
184.6
|
|
||
Total accrued expenses and other current liabilities
|
$
|
1,655.6
|
|
|
$
|
1,522.3
|
|
|
|
September 30, 2015
|
|
December 31, 2014
|
||||
|
|
(in millions)
|
||||||
Notes outstanding under revolving credit facility
|
|
$
|
—
|
|
|
$
|
650.0
|
|
Term loan - current maturities
|
|
50.0
|
|
|
50.0
|
|
||
Total short-term debt
|
|
$
|
50.0
|
|
|
$
|
700.0
|
|
|
|
September 30, 2015
|
|
December 31, 2014
|
||||
|
|
(in millions)
|
||||||
Term loan, due 2019
|
|
$
|
950.0
|
|
|
$
|
987.5
|
|
Less: current maturities
|
|
(50.0
|
)
|
|
(50.0
|
)
|
||
Long-term debt, net of current maturities
|
|
$
|
900.0
|
|
|
$
|
937.5
|
|
|
Three Months Ended
September 30, |
|
Nine Months Ended
September 30, |
||||||||
|
2015
|
|
2014
|
|
2015
|
|
2014
|
||||
Effective income tax rate
|
26.9
|
%
|
|
23.3
|
%
|
|
25.1
|
%
|
|
25.2
|
%
|
•
|
Level 1 – Inputs are quoted prices in active markets for identical assets or liabilities.
|
•
|
Level 2 – Inputs are quoted prices for similar assets or liabilities in an active market, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable and market-corroborated inputs which are derived principally from or corroborated by observable market data.
|
•
|
Level 3 – Inputs are derived from valuation techniques in which one or more significant inputs or value drivers are unobservable.
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Total
|
||||||||
|
(in millions)
|
||||||||||||||
Cash equivalents:
|
|
|
|
|
|
|
|
||||||||
Money market funds
|
$
|
308.4
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
308.4
|
|
Commercial paper
|
—
|
|
|
7.9
|
|
|
—
|
|
|
7.9
|
|
||||
Total cash equivalents
|
308.4
|
|
|
7.9
|
|
|
—
|
|
|
316.3
|
|
||||
Short-term investments:
|
|
|
|
|
|
|
|
||||||||
Time deposits
|
—
|
|
|
740.2
|
|
|
—
|
|
|
740.2
|
|
||||
Available-for-sale investment securities:
|
|
|
|
|
|
|
|
||||||||
U.S. Treasury and agency debt securities
|
458.1
|
|
|
91.8
|
|
|
—
|
|
|
549.9
|
|
||||
Corporate and other debt securities
|
—
|
|
|
354.5
|
|
|
—
|
|
|
354.5
|
|
||||
Certificates of deposit and commercial paper
|
—
|
|
|
553.8
|
|
|
—
|
|
|
553.8
|
|
||||
Asset-backed securities
|
—
|
|
|
231.3
|
|
|
—
|
|
|
231.3
|
|
||||
Municipal debt securities
|
—
|
|
|
121.9
|
|
|
—
|
|
|
121.9
|
|
||||
Mutual funds
|
—
|
|
|
22.4
|
|
|
—
|
|
|
22.4
|
|
||||
Total available-for-sale investment securities
|
458.1
|
|
|
1,375.7
|
|
|
—
|
|
|
1,833.8
|
|
||||
Total short-term investments
|
458.1
|
|
|
2,115.9
|
|
|
—
|
|
|
2,574.0
|
|
||||
Derivative financial instruments - foreign exchange forward contracts:
|
|
|
|
|
|
|
|
||||||||
Other current assets
|
—
|
|
|
6.0
|
|
|
—
|
|
|
6.0
|
|
||||
Accrued expenses and other current liabilities
|
—
|
|
|
(30.7
|
)
|
|
—
|
|
|
(30.7
|
)
|
||||
Other noncurrent assets
|
—
|
|
|
0.4
|
|
|
—
|
|
|
0.4
|
|
||||
Other noncurrent liabilities
|
—
|
|
|
(29.0
|
)
|
|
—
|
|
|
(29.0
|
)
|
||||
Total
|
$
|
766.5
|
|
|
$
|
2,070.5
|
|
|
$
|
—
|
|
|
$
|
2,837.0
|
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Total
|
||||||||
|
(in millions)
|
||||||||||||||
Cash equivalents:
|
|
|
|
|
|
|
|
||||||||
Money market funds
|
$
|
176.5
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
176.5
|
|
Commercial paper
|
—
|
|
|
7.4
|
|
|
—
|
|
|
7.4
|
|
||||
Total cash equivalents
|
176.5
|
|
|
7.4
|
|
|
—
|
|
|
183.9
|
|
||||
Short-term investments:
|
|
|
|
|
|
|
|
||||||||
Time deposits
|
—
|
|
|
501.9
|
|
|
—
|
|
|
501.9
|
|
||||
Available-for-sale investment securities:
|
|
|
|
|
|
|
|
||||||||
U.S. Treasury and agency debt securities
|
426.8
|
|
|
117.9
|
|
|
—
|
|
|
544.7
|
|
||||
Corporate and other debt securities
|
—
|
|
|
358.6
|
|
|
—
|
|
|
358.6
|
|
||||
Certificates of deposit and commercial paper
|
—
|
|
|
4.6
|
|
|
—
|
|
|
4.6
|
|
||||
Asset-backed securities
|
—
|
|
|
220.1
|
|
|
—
|
|
|
220.1
|
|
||||
Municipal debt securities
|
—
|
|
|
112.8
|
|
|
—
|
|
|
112.8
|
|
||||
Mutual funds
|
—
|
|
|
21.9
|
|
|
—
|
|
|
21.9
|
|
||||
Total available-for-sale investment securities
|
426.8
|
|
|
835.9
|
|
|
—
|
|
|
1,262.7
|
|
||||
Total short-term investments
|
426.8
|
|
|
1,337.8
|
|
|
—
|
|
|
1,764.6
|
|
||||
Derivative financial instruments - foreign exchange forward contracts:
|
|
|
|
|
|
|
|
||||||||
Other current assets
|
—
|
|
|
2.7
|
|
|
—
|
|
|
2.7
|
|
||||
Accrued expenses and other current liabilities
|
—
|
|
|
(97.3
|
)
|
|
—
|
|
|
(97.3
|
)
|
||||
Other noncurrent assets
|
—
|
|
|
3.9
|
|
|
—
|
|
|
3.9
|
|
||||
Other noncurrent liabilities
|
—
|
|
|
(10.0
|
)
|
|
—
|
|
|
(10.0
|
)
|
||||
Total
|
$
|
603.3
|
|
|
$
|
1,244.5
|
|
|
$
|
—
|
|
|
$
|
1,847.8
|
|
|
|
|
|
September 30, 2015
|
|
December 31, 2014
|
||||||||||||
Designation of Derivatives
|
|
Location on Statement of
Financial Position
|
|
Assets
|
|
Liabilities
|
|
Assets
|
|
Liabilities
|
||||||||
|
|
|
|
(in millions)
|
||||||||||||||
Cash Flow Hedges – Designated as hedging instruments
|
|
|
|
|
|
|
|
|
|
|
||||||||
Foreign exchange forward contracts
|
|
Other current assets
|
|
$
|
4.9
|
|
|
$
|
—
|
|
|
$
|
0.7
|
|
|
$
|
—
|
|
|
|
Other noncurrent assets
|
|
0.4
|
|
|
—
|
|
|
3.9
|
|
|
—
|
|
||||
|
|
Accrued expenses and other current liabilities
|
|
—
|
|
|
30.5
|
|
|
—
|
|
|
97.2
|
|
||||
|
|
Other noncurrent liabilities
|
|
—
|
|
|
29.0
|
|
|
—
|
|
|
10.0
|
|
||||
|
|
Total
|
|
5.3
|
|
|
59.5
|
|
|
4.6
|
|
|
107.2
|
|
||||
Other Derivatives – Not designated as hedging instruments
|
|
|
|
|
|
|
|
|
|
|
||||||||
Foreign exchange forward contracts
|
|
Other current assets
|
|
1.1
|
|
|
—
|
|
|
2.0
|
|
|
—
|
|
||||
|
|
Accrued expenses and other current liabilities
|
|
—
|
|
|
0.2
|
|
|
—
|
|
|
0.1
|
|
||||
|
|
Total
|
|
1.1
|
|
|
0.2
|
|
|
2.0
|
|
|
0.1
|
|
||||
Total
|
|
|
|
$
|
6.4
|
|
|
$
|
59.7
|
|
|
$
|
6.6
|
|
|
$
|
107.3
|
|
|
September 30, 2015
|
|
December 31, 2014
|
||||
|
(in millions)
|
||||||
2015
|
$
|
330.0
|
|
|
$
|
1,320.0
|
|
2016
|
1,110.0
|
|
|
720.0
|
|
||
2017
|
840.0
|
|
|
420.0
|
|
||
2018
|
330.0
|
|
|
—
|
|
||
Total notional value of contracts outstanding
|
$
|
2,610.0
|
|
|
$
|
2,460.0
|
|
Net unrealized (loss) included in accumulated other comprehensive income (loss), net of taxes
|
$
|
(44.4
|
)
|
|
$
|
(86.7
|
)
|
|
(Increase) Decrease in
Derivative
Losses Recognized
in Accumulated Other
Comprehensive Income (Loss)
(effective portion)
|
|
Location of Net Derivative
(Losses) Reclassified
from Accumulated Other
Comprehensive Income (Loss)
into Income
(effective portion)
|
|
Net (Loss) Reclassified
from Accumulated Other
Comprehensive Income (Loss)
into Income
(effective portion)
|
||||||||||||
|
2015
|
|
2014
|
|
|
|
2015
|
|
2014
|
||||||||
|
(in millions)
|
||||||||||||||||
Cash Flow Hedges – Designated as hedging instruments
|
|
|
|
|
|
|
|
|
|
||||||||
Foreign exchange forward contracts
|
$
|
(29.1
|
)
|
|
$
|
(5.4
|
)
|
|
Cost of revenues
|
|
$
|
(17.5
|
)
|
|
$
|
(25.6
|
)
|
|
|
|
|
|
Selling, general and administrative expenses
|
|
(3.4
|
)
|
|
(5.3
|
)
|
||||||
|
|
|
|
|
Total
|
|
$
|
(20.9
|
)
|
|
$
|
(30.9
|
)
|
|
(Increase) Decrease in
Derivative
Losses Recognized
in Accumulated Other
Comprehensive Income (Loss)
(effective portion)
|
|
Location of Net Derivative
(Losses) Reclassified
from Accumulated Other
Comprehensive Income (Loss)
into Income
(effective portion)
|
|
Net (Loss) Reclassified
from Accumulated Other
Comprehensive Income (Loss)
into Income
(effective portion)
|
||||||||||||
|
2015
|
|
2014
|
|
|
|
2015
|
|
2014
|
||||||||
|
(in millions)
|
||||||||||||||||
Cash Flow Hedges – Designated as hedging instruments
|
|
|
|
|
|
|
|
|
|
||||||||
Foreign exchange forward contracts
|
$
|
(3.4
|
)
|
|
$
|
115.6
|
|
|
Cost of revenues
|
|
$
|
(42.8
|
)
|
|
$
|
(84.7
|
)
|
|
|
|
|
|
Selling, general and administrative expenses
|
|
(9.0
|
)
|
|
(17.5
|
)
|
||||||
|
|
|
|
|
Total
|
|
$
|
(51.8
|
)
|
|
$
|
(102.2
|
)
|
|
September 30, 2015
|
|
December 31, 2014
|
||||||||||||
|
Notional
|
|
Market Value
|
|
|
Notional
|
|
Market Value
|
|
||||||
|
(in millions)
|
||||||||||||||
Contracts to purchase U.S. dollars and sell:
|
|
|
|
|
|
|
|
||||||||
Indian rupees
|
$
|
150.7
|
|
|
$
|
0.6
|
|
|
$
|
160.0
|
|
|
$
|
1.8
|
|
Euros
|
8.1
|
|
|
0.1
|
|
|
24.4
|
|
|
0.2
|
|
||||
British pounds
|
—
|
|
|
—
|
|
|
17.9
|
|
|
—
|
|
||||
Australian dollars
|
9.1
|
|
|
$
|
0.2
|
|
|
9.6
|
|
|
(0.1
|
)
|
|||
Canadian dollars
|
3.3
|
|
|
—
|
|
|
3.7
|
|
|
—
|
|
||||
Total
|
$
|
171.2
|
|
|
$
|
0.9
|
|
|
$
|
215.6
|
|
|
$
|
1.9
|
|
|
Location of Net Gains (Losses) on
Derivative Instruments
|
|
Amount of Net Gains (Losses) on Derivative Instruments
|
||||||||||||||
|
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||||||||||
|
|
|
2015
|
|
2014
|
|
2015
|
|
2014
|
||||||||
|
|
|
(in millions)
|
||||||||||||||
Other Derivatives – Not designated as hedging instruments
|
Foreign currency exchange gains (losses), net
|
|
|
|
|
|
|
|
|
||||||||
Foreign exchange forward contracts
|
|
|
$
|
3.2
|
|
|
$
|
5.8
|
|
|
$
|
1.5
|
|
|
$
|
(6.8
|
)
|
|
Three Months
|
|
Nine Months
|
||||||||||||||||||||
|
Before Tax
Amount
|
|
Tax
Effect
|
|
Net of Tax
Amount
|
|
Before Tax
Amount |
|
Tax
Effect |
|
Net of Tax
Amount |
||||||||||||
|
(in millions)
|
||||||||||||||||||||||
Foreign currency translation adjustments:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Beginning balance
|
$
|
(52.4
|
)
|
|
$
|
—
|
|
|
$
|
(52.4
|
)
|
|
$
|
(34.8
|
)
|
|
$
|
—
|
|
|
$
|
(34.8
|
)
|
Change in foreign currency translation adjustments
|
(16.8
|
)
|
|
—
|
|
|
(16.8
|
)
|
|
(34.4
|
)
|
|
—
|
|
|
(34.4
|
)
|
||||||
Ending balance
|
$
|
(69.2
|
)
|
|
$
|
—
|
|
|
$
|
(69.2
|
)
|
|
$
|
(69.2
|
)
|
|
$
|
—
|
|
|
$
|
(69.2
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Unrealized gains (losses) on available-for-sale investment securities:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Beginning balance
|
$
|
(0.5
|
)
|
|
$
|
—
|
|
|
$
|
(0.5
|
)
|
|
$
|
(2.4
|
)
|
|
$
|
0.8
|
|
|
$
|
(1.6
|
)
|
Net unrealized gains arising during the period
|
1.4
|
|
|
(0.6
|
)
|
|
0.8
|
|
|
4.0
|
|
|
(1.8
|
)
|
|
2.2
|
|
||||||
Reclassification of net (gains) to Other, net
|
(0.2
|
)
|
|
0.2
|
|
|
—
|
|
|
(0.9
|
)
|
|
0.6
|
|
|
(0.3
|
)
|
||||||
Net change
|
1.2
|
|
|
(0.4
|
)
|
|
0.8
|
|
|
3.1
|
|
|
(1.2
|
)
|
|
1.9
|
|
||||||
Ending balance
|
$
|
0.7
|
|
|
$
|
(0.4
|
)
|
|
$
|
0.3
|
|
|
$
|
0.7
|
|
|
$
|
(0.4
|
)
|
|
$
|
0.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Unrealized (losses) on cash flow hedges:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Beginning balance
|
$
|
(46.0
|
)
|
|
$
|
8.4
|
|
|
$
|
(37.6
|
)
|
|
$
|
(102.6
|
)
|
|
$
|
15.9
|
|
|
$
|
(86.7
|
)
|
Unrealized (losses) arising during the period
|
(29.1
|
)
|
|
5.2
|
|
|
(23.9
|
)
|
|
(3.4
|
)
|
|
3.2
|
|
|
(0.2
|
)
|
||||||
Reclassifications of losses to:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Cost of revenues
|
17.5
|
|
|
(3.2
|
)
|
|
14.3
|
|
|
42.8
|
|
|
(7.7
|
)
|
|
35.1
|
|
||||||
Selling, general and administrative expenses
|
3.4
|
|
|
(0.6
|
)
|
|
2.8
|
|
|
9.0
|
|
|
(1.6
|
)
|
|
7.4
|
|
||||||
Net change
|
(8.2
|
)
|
|
1.4
|
|
|
(6.8
|
)
|
|
48.4
|
|
|
(6.1
|
)
|
|
42.3
|
|
||||||
Ending balance
|
$
|
(54.2
|
)
|
|
$
|
9.8
|
|
|
$
|
(44.4
|
)
|
|
$
|
(54.2
|
)
|
|
$
|
9.8
|
|
|
$
|
(44.4
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Accumulated other comprehensive income (loss):
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Beginning balance
|
$
|
(98.9
|
)
|
|
$
|
8.4
|
|
|
$
|
(90.5
|
)
|
|
$
|
(139.8
|
)
|
|
$
|
16.7
|
|
|
$
|
(123.1
|
)
|
Other comprehensive income (loss)
|
(23.8
|
)
|
|
1.0
|
|
|
(22.8
|
)
|
|
17.1
|
|
|
(7.3
|
)
|
|
9.8
|
|
||||||
Ending balance
|
$
|
(122.7
|
)
|
|
$
|
9.4
|
|
|
$
|
(113.3
|
)
|
|
$
|
(122.7
|
)
|
|
$
|
9.4
|
|
|
$
|
(113.3
|
)
|
|
Three Months
|
|
Nine Months
|
||||||||||||||||||||
|
Before Tax
Amount
|
|
Tax
Effect
|
|
Net of Tax
Amount
|
|
Before Tax
Amount |
|
Tax
Effect |
|
Net of Tax
Amount |
||||||||||||
|
(in millions)
|
||||||||||||||||||||||
Foreign currency translation adjustments:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Beginning balance
|
$
|
25.2
|
|
|
$
|
—
|
|
|
$
|
25.2
|
|
|
$
|
24.0
|
|
|
$
|
—
|
|
|
$
|
24.0
|
|
Change in foreign currency translation adjustments
|
(32.0
|
)
|
|
—
|
|
|
(32.0
|
)
|
|
(30.8
|
)
|
|
—
|
|
|
(30.8
|
)
|
||||||
Ending balance
|
$
|
(6.8
|
)
|
|
$
|
—
|
|
|
$
|
(6.8
|
)
|
|
$
|
(6.8
|
)
|
|
$
|
—
|
|
|
$
|
(6.8
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Unrealized gains (losses) on available-for-sale investment securities:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Beginning balance
|
$
|
1.3
|
|
|
$
|
(0.5
|
)
|
|
$
|
0.8
|
|
|
$
|
(0.4
|
)
|
|
$
|
0.1
|
|
|
$
|
(0.3
|
)
|
Net unrealized (losses) gains arising during the period
|
(2.3
|
)
|
|
0.9
|
|
|
(1.4
|
)
|
|
0.1
|
|
|
—
|
|
|
0.1
|
|
||||||
Reclassification of net (gains) to Other, net
|
(0.6
|
)
|
|
0.2
|
|
|
(0.4
|
)
|
|
(1.3
|
)
|
|
0.5
|
|
|
(0.8
|
)
|
||||||
Net change
|
(2.9
|
)
|
|
1.1
|
|
|
(1.8
|
)
|
|
(1.2
|
)
|
|
0.5
|
|
|
(0.7
|
)
|
||||||
Ending balance
|
$
|
(1.6
|
)
|
|
$
|
0.6
|
|
|
$
|
(1.0
|
)
|
|
$
|
(1.6
|
)
|
|
$
|
0.6
|
|
|
$
|
(1.0
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Unrealized gains (losses) on cash flow hedges:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Beginning balance
|
$
|
(162.6
|
)
|
|
$
|
25.1
|
|
|
$
|
(137.5
|
)
|
|
$
|
(354.9
|
)
|
|
$
|
54.9
|
|
|
$
|
(300.0
|
)
|
Unrealized (losses) gains arising during the period
|
(5.4
|
)
|
|
0.9
|
|
|
(4.5
|
)
|
|
115.6
|
|
|
(17.9
|
)
|
|
97.7
|
|
||||||
Reclassifications of losses to:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Cost of revenues
|
25.6
|
|
|
(4.0
|
)
|
|
21.6
|
|
|
84.7
|
|
|
(13.1
|
)
|
|
71.6
|
|
||||||
Selling, general and administrative expenses
|
5.3
|
|
|
(0.8
|
)
|
|
4.5
|
|
|
17.5
|
|
|
(2.7
|
)
|
|
14.8
|
|
||||||
Net change
|
25.5
|
|
|
(3.9
|
)
|
|
21.6
|
|
|
217.8
|
|
|
(33.7
|
)
|
|
184.1
|
|
||||||
Ending balance
|
$
|
(137.1
|
)
|
|
$
|
21.2
|
|
|
$
|
(115.9
|
)
|
|
$
|
(137.1
|
)
|
|
$
|
21.2
|
|
|
$
|
(115.9
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Accumulated other comprehensive income (loss):
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Beginning balance
|
$
|
(136.1
|
)
|
|
$
|
24.6
|
|
|
$
|
(111.5
|
)
|
|
$
|
(331.3
|
)
|
|
$
|
55.0
|
|
|
$
|
(276.3
|
)
|
Other comprehensive income (loss)
|
(9.4
|
)
|
|
(2.8
|
)
|
|
(12.2
|
)
|
|
185.8
|
|
|
(33.2
|
)
|
|
152.6
|
|
||||||
Ending balance
|
$
|
(145.5
|
)
|
|
$
|
21.8
|
|
|
$
|
(123.7
|
)
|
|
$
|
(145.5
|
)
|
|
$
|
21.8
|
|
|
$
|
(123.7
|
)
|
•
|
Financial Services, which includes customers providing banking/transaction processing, capital markets and insurance services;
|
•
|
Healthcare, which includes healthcare providers and payers as well as life sciences customers, including pharmaceutical, biotech and medical device companies;
|
•
|
Manufacturing/Retail/Logistics, which includes consumer goods, manufacturers, retailers, travel and other hospitality customers, as well as customers providing logistics services; and
|
•
|
Other, which is an aggregation of industry segments each of which, individually, represents less than
10%
of consolidated revenues and segment operating profit. The Other reportable segment includes our information, media and entertainment services, communications and high technology operating segments. Our sales managers, account executives, account managers and project teams are aligned in accordance with the specific industries they serve.
|
|
Three Months Ended
September 30, |
|
Nine Months Ended
September 30, |
||||||||||||
|
2015
|
|
2014
|
|
2015
|
|
2014
|
||||||||
|
(in millions)
|
||||||||||||||
Revenues:
|
|
|
|
|
|
|
|
||||||||
Financial Services
|
$
|
1,284.0
|
|
|
$
|
1,082.2
|
|
|
$
|
3,695.2
|
|
|
$
|
3,164.5
|
|
Healthcare
|
939.2
|
|
|
655.4
|
|
|
2,715.6
|
|
|
1,916.8
|
|
||||
Manufacturing/Retail/Logistics
|
606.2
|
|
|
533.1
|
|
|
1,733.4
|
|
|
1,559.3
|
|
||||
Other
|
357.6
|
|
|
310.3
|
|
|
1,039.3
|
|
|
879.9
|
|
||||
Total revenue
|
$
|
3,187.0
|
|
|
$
|
2,581.0
|
|
|
$
|
9,183.5
|
|
|
$
|
7,520.5
|
|
Segment Operating Profit:
|
|
|
|
|
|
|
|
||||||||
Financial Services
|
$
|
430.0
|
|
|
$
|
318.0
|
|
|
$
|
1,197.5
|
|
|
$
|
1,019.9
|
|
Healthcare
|
322.8
|
|
|
200.8
|
|
|
885.4
|
|
|
642.4
|
|
||||
Manufacturing/Retail/Logistics
|
215.5
|
|
|
168.7
|
|
|
598.0
|
|
|
527.8
|
|
||||
Other
|
117.3
|
|
|
96.8
|
|
|
332.2
|
|
|
290.5
|
|
||||
Total segment operating profit
|
1,085.6
|
|
|
784.3
|
|
|
3,013.1
|
|
|
2,480.6
|
|
||||
Less: unallocated costs
|
542.8
|
|
|
326.8
|
|
|
1,424.5
|
|
|
1,075.1
|
|
||||
Income from operations
|
$
|
542.8
|
|
|
$
|
457.5
|
|
|
$
|
1,588.6
|
|
|
$
|
1,405.5
|
|
|
Three Months Ended
September 30, |
|
Nine Months Ended
September 30, |
||||||||||||
|
2015
|
|
2014
|
|
2015
|
|
2014
|
||||||||
|
(in millions)
|
||||||||||||||
Revenues:
(1)
|
|
|
|
|
|
|
|
||||||||
North America
(2)
|
$
|
2,510.6
|
|
|
$
|
1,981.2
|
|
|
$
|
7,226.5
|
|
|
$
|
5,746.0
|
|
Europe
(3)
|
509.1
|
|
|
472.1
|
|
|
1,487.3
|
|
|
1,408.5
|
|
||||
Rest of World
(4)
|
167.3
|
|
|
127.7
|
|
|
469.7
|
|
|
366.0
|
|
||||
Total
|
$
|
3,187.0
|
|
|
$
|
2,581.0
|
|
|
$
|
9,183.5
|
|
|
$
|
7,520.5
|
|
|
As of
|
||||||
|
September 30, 2015
|
|
December 31, 2014
|
||||
|
(in millions)
|
||||||
Long-lived Assets:
(5)
|
|
|
|
||||
North America
(2)
|
$
|
231.0
|
|
|
$
|
188.3
|
|
Europe
|
32.3
|
|
|
29.8
|
|
||
Rest of World
(4)(6)
|
1,015.6
|
|
|
1,029.1
|
|
||
Total
|
$
|
1,278.9
|
|
|
$
|
1,247.2
|
|
(1)
|
Revenues are attributed to regions based upon customer location.
|
(2)
|
Substantially all relates to operations in the United States.
|
(3)
|
Includes revenue from operations in the United Kingdom of
$299.9 million
and $
277.0 million
for the three months ended
September 30, 2015
and
2014
, respectively, and
$882.6 million
and $
820.5 million
for the nine months ended
September 30, 2015
and
2014
, respectively.
|
(4)
|
Includes our operations in Asia Pacific, the Middle East and Latin America.
|
(5)
|
Long-lived assets include property and equipment, net of accumulated depreciation and amortization.
|
(6)
|
Substantially all of these long-lived assets relate to our operations in India.
|
•
|
Our November 2014 acquisition of TZ US Parent, Inc., or TriZetto, which contributed revenue of approximately $190.9 million and was one of the drivers of the
43.3%
revenue growth in our Healthcare business segment;
|
•
|
Solid performance across all of our business segments with revenue growth of
18.6%
for Financial Services,
43.3%
for Healthcare (inclusive of TriZetto revenue),
13.7%
for Manufacturing/Retail/Logisitics, and
15.2%
for Other;
|
•
|
Sustained strength in the North American market where revenues grew
26.7%
, inclusive of TriZetto revenue, as compared to the quarter ended
September 30, 2014
;
|
•
|
Continued penetration of the European and Rest of World (primarily the Asia Pacific) markets. Revenue from our customers outside the United States was negatively affected by the recent strength of the U.S. dollar against the British pound, the Euro and other currencies. In Europe, we experienced revenue growth of
7.8%
, after a negative currency impact of 10.4%, as compared to the quarter ended
September 30, 2014
. Revenue from our Rest of World customers increased
31.0%
, after a negative currency impact of 12.5%, as compared to the quarter ended
September 30, 2014
;
|
•
|
Increased customer spending on discretionary projects;
|
•
|
Expansion of our service offerings, including consulting, infrastructure services, and business process services, which enabled us to cross-sell new services to our customers and meet the rapidly growing demand for complex large-scale outsourcing solutions;
|
•
|
Increased penetration at existing customers, including strategic clients; and
|
•
|
Continued expansion of the market for global delivery of IT and business process services.
|
1
|
Non-GAAP diluted earnings per share is not a measurement of financial performance prepared in accordance with GAAP. See “Non-GAAP Financial Measures” for more information and a reconciliation to the most directly comparable GAAP financial measure.
|
•
|
Continued focus by customers on directing IT spending towards cost containment projects, such as application maintenance, infrastructure services and business process services;
|
•
|
Demand from our customers to help them achieve their dual mandate of simultaneously achieving cost savings while investing in transformation and innovation;
|
•
|
Secular changes driven by evolving digital technologies and regulatory changes;
|
•
|
Volatility in foreign currency rates;
|
•
|
Continued uncertainty in the world economy; and
|
•
|
Addition of the TriZetto business.
|
2
|
Non-GAAP operating margin is not a measurement of financial performance prepared in accordance with GAAP. See “Non-GAAP Financial Measures” for more information and a reconciliation to the most directly comparable GAAP financial measure.
|
•
|
Invest in our talent base and new service offerings, including digital technologies and new delivery models;
|
•
|
Partner with our existing customers to garner an increased portion of our customers’ overall IT spend by providing innovative solutions;
|
•
|
Focus on growing our business in Europe, the Middle East, the Asia Pacific and Latin America regions, where we believe there are opportunities to gain market share;
|
•
|
Increase our strategic customer base across all of our business segments;
|
•
|
Opportunistically look for acquisitions that may improve our overall service delivery capabilities, expand our geographic presence and/or enable us to enter new areas of technology;
|
•
|
Focus on operating discipline in order to appropriately manage our cost structure;
|
•
|
Locate most of our new development center facilities in tax incentivized areas; and
|
•
|
Leverage assets and capabilities obtained from the 2014 TriZetto acquisition to aggressively pursue new opportunities in the marketplace.
|
•
|
Financial Services, which includes customers providing banking/transaction processing, capital markets and insurance services;
|
•
|
Healthcare, which includes healthcare providers and payers as well as life sciences customers, including pharmaceutical, biotech and medical device companies;
|
•
|
Manufacturing/Retail/Logistics, which includes consumer goods manufacturers, retailers, travel and other hospitality customers, as well as customers providing logistics services; and
|
•
|
Other, which is an aggregation of industry operating segments each of which, individually, represents less than 10.0% of consolidated revenues and segment operating profit. The Other reportable segment includes our information, media and entertainment services, communications, and high technology operating segments.
|
|
|
|
% of
|
|
|
|
% of
|
|
Increase
(Decrease)
|
|||||||||
|
2015
|
|
Revenues
|
|
2014
|
|
Revenues
|
|
$
|
|
%
|
|||||||
|
(Dollars in millions, except per share data)
|
|||||||||||||||||
Revenues
|
$
|
3,187.0
|
|
|
100.0
|
|
$
|
2,581.0
|
|
|
100.0
|
|
$
|
606.0
|
|
|
23.5
|
|
Cost of revenues
(1)
|
1,934.6
|
|
|
60.7
|
|
1,569.8
|
|
|
60.8
|
|
364.8
|
|
|
23.2
|
|
|||
Selling, general and administrative expenses
(1)
|
627.1
|
|
|
19.7
|
|
506.0
|
|
|
19.6
|
|
121.1
|
|
|
23.9
|
|
|||
Depreciation and amortization expense
|
82.5
|
|
|
2.6
|
|
47.7
|
|
|
1.8
|
|
34.8
|
|
|
73.0
|
|
|||
Income from operations
|
542.8
|
|
|
17.0
|
|
457.5
|
|
|
17.7
|
|
85.3
|
|
|
18.6
|
|
|||
Other income (expense), net
|
0.2
|
|
|
|
|
6.2
|
|
|
|
|
(6.0
|
)
|
|
(96.8
|
)
|
|||
Income before provision for income taxes
|
543.0
|
|
|
17.0
|
|
463.7
|
|
|
18.0
|
|
79.3
|
|
|
17.1
|
|
|||
Provision for income taxes
|
145.8
|
|
|
|
|
108.1
|
|
|
|
|
37.7
|
|
|
34.9
|
|
|||
Net income
|
$
|
397.2
|
|
|
12.5
|
|
$
|
355.6
|
|
|
13.8
|
|
$
|
41.6
|
|
|
11.7
|
|
Diluted earnings per share
|
$
|
0.65
|
|
|
|
|
$
|
0.58
|
|
|
|
|
$
|
0.07
|
|
|
|
|
Other Financial Information
(2)
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Non-GAAP income from operations and non-GAAP operating margin
|
$
|
617.8
|
|
|
19.4
|
|
$
|
503.7
|
|
|
19.5
|
|
$
|
114.1
|
|
|
22.7
|
|
Non-GAAP diluted earnings per share
|
$
|
0.76
|
|
|
|
|
$
|
0.66
|
|
|
|
|
$
|
0.10
|
|
|
|
(1)
|
Exclusive of depreciation and amortization expense.
|
(2)
|
Non-GAAP income from operations, non-GAAP operating margin and non-GAAP diluted earnings per share are not measurements of financial performance prepared in accordance with GAAP. See “Non-GAAP Financial Measures” for more information and a reconciliation to the most directly comparable GAAP financial measure.
|
|
|
2015
|
|
2014
|
|
Increase
|
||||||||
$
|
|
%
|
||||||||||||
|
|
(Dollars in millions)
|
||||||||||||
Financial Services
|
|
$
|
1,284.0
|
|
|
$
|
1,082.2
|
|
|
$
|
201.8
|
|
|
18.6
|
Healthcare
|
|
939.2
|
|
|
655.4
|
|
|
283.8
|
|
|
43.3
|
|||
Manufacturing/Retail/Logistics
|
|
606.2
|
|
|
533.1
|
|
|
73.1
|
|
|
13.7
|
|||
Other
|
|
357.6
|
|
|
310.3
|
|
|
47.3
|
|
|
15.2
|
|||
Total revenue
|
|
$
|
3,187.0
|
|
|
$
|
2,581.0
|
|
|
$
|
606.0
|
|
|
23.5
|
|
|
2015
|
|
2014
|
|
Increase
|
||||||||
|
$
|
|
%
|
|||||||||||
|
|
(Dollars in millions)
|
||||||||||||
North America
|
|
$
|
2,510.6
|
|
|
$
|
1,981.2
|
|
|
$
|
529.4
|
|
|
26.7
|
United Kingdom
|
|
299.9
|
|
|
277.0
|
|
|
22.9
|
|
|
8.3
|
|||
Rest of Europe
|
|
209.2
|
|
|
195.1
|
|
|
14.1
|
|
|
7.2
|
|||
Europe - Total
|
|
509.1
|
|
|
472.1
|
|
|
37.0
|
|
|
7.8
|
|||
Rest of World
|
|
167.3
|
|
|
127.7
|
|
|
39.6
|
|
|
31.0
|
|||
Total Revenue
|
|
$
|
3,187.0
|
|
|
$
|
2,581.0
|
|
|
$
|
606.0
|
|
|
23.5
|
|
|
|
|
|
Increase
|
||||||||
|
2015
|
|
2014
|
|
$
|
|
%
|
||||||
|
(Dollars in millions)
|
||||||||||||
Financial Services
|
$
|
430.0
|
|
|
$
|
318.0
|
|
|
$
|
112.0
|
|
|
35.2
|
Healthcare
|
322.8
|
|
|
200.8
|
|
|
122.0
|
|
|
60.8
|
|||
Manufacturing/Retail/Logistics
|
215.5
|
|
|
168.7
|
|
|
46.8
|
|
|
27.7
|
|||
Other
|
117.3
|
|
|
96.8
|
|
|
20.5
|
|
|
21.2
|
|||
Total segment operating profit
|
1,085.6
|
|
|
784.3
|
|
|
301.3
|
|
|
38.4
|
|||
Less: unallocated costs
|
542.8
|
|
|
326.8
|
|
|
216.0
|
|
|
66.1
|
|||
Income from operations
|
$
|
542.8
|
|
|
$
|
457.5
|
|
|
$
|
85.3
|
|
|
18.6
|
3
|
Non-GAAP operating margin is not a measurement of financial performance prepared in accordance with GAAP. See “Non-GAAP Financial Measures” for more information and a reconciliation to the most directly comparable GAAP financial measure.
|
|
2015
|
|
2014
|
|
Increase/
Decrease
|
||||||
|
(in millions)
|
||||||||||
Foreign currency exchange (losses)
|
$
|
(19.0
|
)
|
|
$
|
(17.0
|
)
|
|
$
|
(2.0
|
)
|
Gains on foreign exchange forward contracts not designated as hedging instruments
|
3.2
|
|
|
5.8
|
|
|
(2.6
|
)
|
|||
Net foreign currency exchange (losses)
|
(15.8
|
)
|
|
(11.2
|
)
|
|
(4.6
|
)
|
|||
Interest income
|
20.7
|
|
|
17.2
|
|
|
3.5
|
|
|||
Interest expense
|
(4.3
|
)
|
|
(0.3
|
)
|
|
(4.0
|
)
|
|||
Other, net
|
(0.4
|
)
|
|
0.5
|
|
|
(0.9
|
)
|
|||
Total other income (expense), net
|
$
|
0.2
|
|
|
$
|
6.2
|
|
|
$
|
(6.0
|
)
|
|
2015
|
|
% of
Revenues
|
|
2014
|
|
% of
Revenues
|
||||
|
(Dollars in millions, except per share amounts)
|
||||||||||
GAAP income from operations and operating margin
|
$
|
542.8
|
|
|
17.0
|
|
$
|
457.5
|
|
|
17.7
|
Add: Stock-based compensation expense
|
46.4
|
|
|
1.5
|
|
31.3
|
|
|
1.2
|
||
Add: Acquisition-related charges
(1)
|
28.6
|
|
|
0.9
|
|
14.9
|
|
|
0.6
|
||
Non-GAAP income from operations and non-GAAP operating margin
|
$
|
617.8
|
|
|
19.4
|
|
$
|
503.7
|
|
|
19.5
|
|
|
|
|
|
|
|
|
||||
GAAP diluted earnings per share
|
$
|
0.65
|
|
|
|
|
$
|
0.58
|
|
|
|
Effect of above operating adjustments, net of tax
|
0.09
|
|
|
|
|
0.06
|
|
|
|
||
Effect on non-operating foreign currency exchange losses, net of tax
(2)
|
0.02
|
|
|
|
|
0.02
|
|
|
|
||
Non-GAAP diluted earnings per share
|
$
|
0.76
|
|
|
|
|
$
|
0.66
|
|
|
|
(1)
|
Acquisition-related charges include, when applicable, amortization of purchased intangible assets included in the depreciation and amortization expense line on our condensed consolidated statements of operations, external deal costs, acquisition-related retention bonuses, integration costs, changes in the fair value of contingent consideration liabilities, charges for impairment of acquired intangible assets and other acquisition-related costs.
|
(2)
|
Non-operating foreign currency exchange gains and losses are inclusive of gains and losses on related foreign exchange forward contracts not designated as hedging instruments for accounting purposes.
|
|
|
|
% of
|
|
|
|
% of
|
|
Increase
(Decrease)
|
|||||||||
|
2015
|
|
Revenues
|
|
2014
|
|
Revenues
|
|
$
|
|
%
|
|||||||
|
(Dollars in millions, except per share data)
|
|||||||||||||||||
Revenues
|
$
|
9,183.5
|
|
|
100.0
|
|
$
|
7,520.5
|
|
|
100.0
|
|
$
|
1,663.0
|
|
|
22.1
|
|
Cost of revenues
(1)
|
5,506.6
|
|
|
60.0
|
|
4,501.7
|
|
|
59.9
|
|
1,004.9
|
|
|
22.3
|
|
|||
Selling, general and administrative expenses
(1)
|
1,849.9
|
|
|
20.1
|
|
1,474.4
|
|
|
19.6
|
|
375.5
|
|
|
25.5
|
|
|||
Depreciation and amortization expense
|
238.4
|
|
|
2.6
|
|
138.9
|
|
|
1.8
|
|
99.5
|
|
|
71.6
|
|
|||
Income from operations
|
1,588.6
|
|
|
17.3
|
|
1,405.5
|
|
|
18.7
|
|
183.1
|
|
|
13.0
|
|
|||
Other income (expense), net
|
13.8
|
|
|
|
|
33.3
|
|
|
|
|
(19.5
|
)
|
|
(58.6
|
)
|
|||
Income before provision for income taxes
|
1,602.4
|
|
|
17.4
|
|
1,438.8
|
|
|
19.1
|
|
163.6
|
|
|
11.4
|
|
|||
Provision for income taxes
|
402.2
|
|
|
|
|
362.4
|
|
|
|
|
39.8
|
|
|
11.0
|
|
|||
Net income
|
$
|
1,200.2
|
|
|
13.1
|
|
$
|
1,076.4
|
|
|
14.3
|
|
$
|
123.8
|
|
|
11.5
|
|
Diluted earnings per share
|
$
|
1.96
|
|
|
|
|
$
|
1.76
|
|
|
|
|
$
|
0.20
|
|
|
|
|
Other Financial Information
(2)
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Non-GAAP income from operations and non-GAAP operating margin
|
$
|
1,817.5
|
|
|
19.8
|
|
$
|
1,536.5
|
|
|
20.4
|
|
$
|
281.0
|
|
|
18.3
|
|
Non-GAAP diluted earnings per share
|
$
|
2.27
|
|
|
|
|
$
|
1.94
|
|
|
|
|
$
|
0.33
|
|
|
|
(1)
|
Exclusive of depreciation and amortization expense.
|
(2)
|
Non-GAAP income from operations, non-GAAP operating margin and non-GAAP diluted earnings per share are not measurements of financial performance prepared in accordance with GAAP. See “Non-GAAP Financial Measures” for more information and a reconciliation to the most directly comparable GAAP financial measure.
|
|
|
2015
|
|
2014
|
|
Increase
|
||||||||
$
|
|
%
|
||||||||||||
|
|
(Dollars in millions)
|
||||||||||||
Financial Services
|
|
$
|
3,695.2
|
|
|
$
|
3,164.5
|
|
|
$
|
530.7
|
|
|
16.8
|
Healthcare
|
|
2,715.6
|
|
|
1,916.8
|
|
|
798.8
|
|
|
41.7
|
|||
Manufacturing/Retail/Logistics
|
|
1,733.4
|
|
|
1,559.3
|
|
|
174.1
|
|
|
11.2
|
|||
Other
|
|
1,039.3
|
|
|
879.9
|
|
|
159.4
|
|
|
18.1
|
|||
Total revenue
|
|
$
|
9,183.5
|
|
|
$
|
7,520.5
|
|
|
$
|
1,663.0
|
|
|
22.1
|
|
|
2015
|
|
2014
|
|
Increase
|
||||||||
|
$
|
|
%
|
|||||||||||
|
|
(Dollars in millions)
|
||||||||||||
North America
|
|
$
|
7,226.5
|
|
|
$
|
5,746.0
|
|
|
$
|
1,480.5
|
|
|
25.8
|
United Kingdom
|
|
882.6
|
|
|
820.5
|
|
|
62.1
|
|
|
7.6
|
|||
Rest of Europe
|
|
604.7
|
|
|
588.0
|
|
|
16.7
|
|
|
2.8
|
|||
Europe - Total
|
|
1,487.3
|
|
|
1,408.5
|
|
|
78.8
|
|
|
5.6
|
|||
Rest of World
|
|
469.7
|
|
|
366.0
|
|
|
103.7
|
|
|
28.3
|
|||
Total Revenue
|
|
$
|
9,183.5
|
|
|
$
|
7,520.5
|
|
|
$
|
1,663.0
|
|
|
22.1
|
|
|
|
|
|
Increase
|
||||||||
|
2015
|
|
2014
|
|
$
|
|
%
|
||||||
|
(Dollars in millions)
|
||||||||||||
Financial Services
|
$
|
1,197.5
|
|
|
$
|
1,019.9
|
|
|
$
|
177.6
|
|
|
17.4
|
Healthcare
|
885.4
|
|
|
642.4
|
|
|
243.0
|
|
|
37.8
|
|||
Manufacturing/Retail/Logistics
|
598.0
|
|
|
527.8
|
|
|
70.2
|
|
|
13.3
|
|||
Other
|
332.2
|
|
|
290.5
|
|
|
41.7
|
|
|
14.4
|
|||
Total segment operating profit
|
3,013.1
|
|
|
2,480.6
|
|
|
532.5
|
|
|
21.5
|
|||
Less: unallocated costs
|
1,424.5
|
|
|
1,075.1
|
|
|
349.4
|
|
|
32.5
|
|||
Income from operations
|
$
|
1,588.6
|
|
|
$
|
1,405.5
|
|
|
$
|
183.1
|
|
|
13.0
|
4
|
Non-GAAP operating margin is not a measurement of financial performance prepared in accordance with GAAP. See “Non-GAAP Financial Measures” for more information and a reconciliation to the most directly comparable GAAP financial measure.
|
|
2015
|
|
2014
|
|
Increase/
Decrease
|
||||||
|
(in millions)
|
||||||||||
Foreign currency exchange (losses)
|
$
|
(29.9
|
)
|
|
$
|
(6.4
|
)
|
|
$
|
(23.5
|
)
|
Gains (losses) on foreign exchange forward contracts not designated as hedging instruments
|
1.5
|
|
|
(6.8
|
)
|
|
8.3
|
|
|||
Net foreign currency exchange (losses)
|
(28.4
|
)
|
|
(13.2
|
)
|
|
(15.2
|
)
|
|||
Interest income
|
56.3
|
|
|
44.8
|
|
|
11.5
|
|
|||
Interest expense
|
(13.4
|
)
|
|
(0.3
|
)
|
|
(13.1
|
)
|
|||
Other, net
|
(0.7
|
)
|
|
2.0
|
|
|
(2.7
|
)
|
|||
Total other income (expense), net
|
$
|
13.8
|
|
|
$
|
33.3
|
|
|
$
|
(19.5
|
)
|
|
2015
|
|
% of
Revenues
|
|
2014
|
|
% of
Revenues
|
||||
|
(Dollars in millions, except per share amounts)
|
||||||||||
GAAP income from operations and operating margin
|
$
|
1,588.6
|
|
|
17.3
|
|
$
|
1,405.5
|
|
|
18.7
|
Add: Stock-based compensation expense
|
141.6
|
|
|
1.5
|
|
100.6
|
|
|
1.3
|
||
Add: Acquisition-related charges
(1)
|
87.3
|
|
|
1.0
|
|
30.4
|
|
|
0.4
|
||
Non-GAAP income from operations and non-GAAP operating margin
|
$
|
1,817.5
|
|
|
19.8
|
|
$
|
1,536.5
|
|
|
20.4
|
|
|
|
|
|
|
|
|
||||
GAAP diluted earnings per share
|
$
|
1.96
|
|
|
|
|
$
|
1.76
|
|
|
|
Effect of above operating adjustments, net of tax
|
0.26
|
|
|
|
|
0.17
|
|
|
|
||
Effect on non-operating foreign currency exchange gains and losses, net of tax
(2)
|
0.05
|
|
|
|
|
0.01
|
|
|
|
||
Non-GAAP diluted earnings per share
|
$
|
2.27
|
|
|
|
|
$
|
1.94
|
|
|
|
(1)
|
Acquisition-related charges include, when applicable, amortization of purchased intangible assets included in the depreciation and amortization expense line on our condensed consolidated statements of operations, external deal costs, acquisition-related retention bonuses, integration costs, changes in the fair value of contingent consideration liabilities, charges for impairment of acquired intangible assets and other acquisition-related costs.
|
(2)
|
Non-operating foreign currency exchange gains and losses are inclusive of gains and losses on related foreign exchange forward contracts not designated as hedging instruments for accounting purposes.
|
|
|
2015
|
|
2014
|
|
Increase / Decrease
|
||||||
|
|
(in millions)
|
||||||||||
Net cash from operating activities
|
|
$
|
1,463.3
|
|
|
$
|
1,148.8
|
|
|
$
|
314.5
|
|
Net cash (used in) investing activities
|
|
(1,030.4
|
)
|
|
(626.6
|
)
|
|
(403.8
|
)
|
|||
Net cash (used in) financing activities
|
|
(954.9
|
)
|
|
(108.4
|
)
|
|
(846.5
|
)
|
|
Notional Value (in millions)
|
|
Weighted Average Contract Rate (Indian rupee to U.S. dollar)
|
|||
2015
|
$
|
330.0
|
|
|
62.1
|
|
2016
|
1,110.0
|
|
|
68.1
|
|
|
2017
|
840.0
|
|
|
71.2
|
|
|
2018
|
330.0
|
|
|
74.1
|
|
|
Total
|
$
|
2,610.0
|
|
|
69.1
|
|
•
|
competition from other service providers;
|
•
|
the risk that our operating margin may decline and we may not be able to sustain our current level of profitability;
|
•
|
the risk of liability or damage to our reputation resulting from security breaches;
|
•
|
any possible failure to comply with or adapt to changes in healthcare-related data protection and privacy laws;
|
•
|
the loss of customers, especially as a few customers account for a large portion of our revenues;
|
•
|
the risk that we may not be able to keep pace with the rapidly evolving technological environment;
|
•
|
the rate of growth in the use of technology in business and the type and level of technology spending by our clients;
|
•
|
mispricing of our services, especially as an increasing percentage of our revenues are derived from fixed-price contracts;
|
•
|
the risk that we might not be able to maintain effective internal controls, including as we acquire and integrate other companies;
|
•
|
our inability to successfully acquire or integrate target companies;
|
•
|
system failure or disruptions in our communications or information technology;
|
•
|
the risk that we may lose key executives and not be able to enforce non-competition agreements with them;
|
•
|
competition for hiring highly-skilled technical personnel;
|
•
|
possible failure to provide end-to-end business solutions and deliver complex and large projects for our clients;
|
•
|
the risk of reputational harm to us;
|
•
|
our revenues being highly dependent on clients concentrated in certain industries, including financial services and healthcare, and located primarily in the United States and Europe;
|
•
|
risks relating to our global operations, including our operations in India;
|
•
|
the effects of fluctuations in the Indian rupee and other currency exchange rates;
|
•
|
the effect of our use of derivative instruments;
|
•
|
the risk of war, terrorist activities, pandemics and natural disasters;
|
•
|
the possibility that we may be required, as a result of our indebtedness, or otherwise choose to repatriate foreign earnings or that our foreign earnings or profits may become subject to U.S. taxes;
|
•
|
the possibility that we may lose certain tax benefits provided to companies in our industry by the Indian government;
|
•
|
the risk that we may not be able to enforce or protect our intellectual property rights, or that we may infringe upon the intellectual property rights of others;
|
•
|
changes in domestic and international regulations and legislation relating to immigration and anti-outsourcing;
|
•
|
increased regulation of the financial services and healthcare industries, as well as other industries in which our clients operate; and
|
•
|
the factors set forth in Part I, in the section entitled “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2014.
|
|
Notional Value (in millions)
|
|
Weighted Average Contract Rate (Indian rupee to U.S. dollar)
|
|||
2015
|
$
|
330.0
|
|
|
62.1
|
|
2016
|
1,110.0
|
|
|
68.1
|
|
|
2017
|
840.0
|
|
|
71.2
|
|
|
2018
|
$
|
330.0
|
|
|
74.1
|
|
Total
|
$
|
2,610.0
|
|
|
69.1
|
|
Month
|
|
Total Number
of Shares Purchased |
|
Average
Price Paid per Share |
|
Total Number of
Shares Purchased as Part of Publicly Announced Plans or Programs |
|
Approximate
Dollar Value of Shares that May Yet Be Purchased under the Plans or Programs (in millions) |
||||||
July 1, 2015 - July 31, 2015
|
|
—
|
|
|
$
|
—
|
|
|
—
|
|
|
$
|
636.0
|
|
August 1, 2015 - August 31, 2015
|
|
1,000,000
|
|
|
62.15
|
|
|
1,000,000
|
|
|
573.9
|
|
||
September 1, 2015 - September 30, 2015
|
|
1,500,000
|
|
|
62.59
|
|
|
1,500,000
|
|
|
480.0
|
|
||
Total
|
|
2,500,000
|
|
|
$
|
62.41
|
|
|
2,500,000
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
Incorporated by Reference
|
|
|
|||||||
Number
|
|
Exhibit Description
|
|
Form
|
|
File No.
|
|
Exhibit
|
|
Date
|
|
Filed or Furnished Herewith
|
|
3.1
|
|
Restated Certificate of Incorporation
|
|
8-K
|
|
000-24429
|
|
3.2
|
|
|
9/17/2013
|
|
|
3.2
|
|
Amended and Restated Bylaws, as adopted on June 4, 2013
|
|
8-K
|
|
000-24429
|
|
3.2
|
|
|
6/5/2013
|
|
|
31.1
|
|
Certification of principal executive officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
|
|
|
|
|
|
|
|
Filed
|
|
31.2
|
|
Certification of principal financial officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
|
|
|
|
|
|
|
|
Filed
|
|
32.1
|
|
Certification of principal executive officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. 1350
|
|
|
|
|
|
|
|
|
|
Furnished
|
|
32.2
|
|
Certification of principal financial officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. 1350
|
|
|
|
|
|
|
|
|
|
Furnished
|
|
101.INS
|
|
XBRL Instance Document
|
|
|
|
|
|
|
|
|
|
Filed
|
|
101.SCH
|
|
XBRL Taxonomy Extension Schema Document
|
|
|
|
|
|
|
|
|
|
Filed
|
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
|
|
|
|
|
|
|
Filed
|
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
|
|
|
|
|
|
|
|
Filed
|
|
101.LAB
|
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
|
|
|
|
|
|
|
|
Filed
|
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
|
|
|
|
|
|
|
|
Filed
|
|
|
|
Cognizant Technology Solutions Corporation
|
|||
|
|
|
|
|
||
Date:
|
November 5, 2015
|
|
|
By:
|
|
/s/ Francisco D’Souza
|
|
|
|
|
|
|
Francisco D’Souza,
|
|
|
|
|
|
|
Chief Executive Officer
|
|
|
|
|
|
|
(Principal Executive Officer)
|
|
|
|
|
|
|
|
Date:
|
November 5, 2015
|
|
|
By:
|
|
/s/ Karen McLoughlin
|
|
|
|
|
|
|
Karen McLoughlin,
|
|
|
|
|
|
|
Chief Financial Officer
|
|
|
|
|
|
|
(Principal Financial and Accounting Officer)
|
|
|
|
|
Incorporated by Reference
|
|
|
|||||||
Number
|
|
Exhibit Description
|
|
Form
|
|
File No.
|
|
Exhibit
|
|
Date
|
|
Filed or Furnished Herewith
|
|
3.1
|
|
Restated Certificate of Incorporation
|
|
8-K
|
|
000-24429
|
|
3.2
|
|
|
9/17/2013
|
|
|
3.2
|
|
Amended and Restated Bylaws, as adopted on June 4, 2013
|
|
8-K
|
|
000-24429
|
|
3.2
|
|
|
6/5/2013
|
|
|
31.1
|
|
Certification of principal executive officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
|
|
|
|
|
|
|
|
Filed
|
|
31.2
|
|
Certification of principal financial officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
|
|
|
|
|
|
|
|
Filed
|
|
32.1
|
|
Certification of principal executive officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. 1350
|
|
|
|
|
|
|
|
|
|
Furnished
|
|
32.2
|
|
Certification of principal financial officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. 1350
|
|
|
|
|
|
|
|
|
|
Furnished
|
|
101.INS
|
|
XBRL Instance Document
|
|
|
|
|
|
|
|
|
|
Filed
|
|
101.SCH
|
|
XBRL Taxonomy Extension Schema Document
|
|
|
|
|
|
|
|
|
|
Filed
|
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
|
|
|
|
|
|
|
Filed
|
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
|
|
|
|
|
|
|
|
Filed
|
|
101.LAB
|
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
|
|
|
|
|
|
|
|
Filed
|
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
|
|
|
|
|
|
|
|
Filed
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
---|
DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
---|
No information found
Customers
Customer name | Ticker |
---|---|
KeyCorp | KEY |
KeyCorp | KEY |
Microsoft Corporation | MSFT |
UnitedHealth Group Incorporated | UNH |
No Suppliers Found
Price
Yield
Owner | Position | Direct Shares | Indirect Shares |
---|